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Abstract: Background: Cancer research focuses increasingly on
cancer stem cell study as those cells are thought to be the root
of chemo and radioresistance of the most aggressive cancer
types. Nevertheless, two-dimensional (2D) cell culture and even
three-dimensional (3D) spheroid models, with their limited abil-
ity to reflect cell-extracellular matrix interactions, are not ideal
for the study of cancer stem cells (CSCs). In this study, we
establish a 3D in vitro cancer model using a synthetic and nat-
ural scaffold with tunable features and show that U87 cells cul-
tured in this system acquire a stem-cell like phenotype.
Methods: U87 astrocytoma cells were grown on polycaprolac-
tone (PCL)22D flat substrates (2D) and PCL-3D scaffolds (3D)
eventually containing hyaluronic acid (3D-HA). Cell viability,
growth patterns, morphology, and cell surface marker expres-
sion (CD44, RHAMM and CD133) were studied to assess the
effect of 3D culture and presence of HA. Results: 3D scaffold,
but most prominently presence of HA induced changes in cell
morphology and marker expression; 3D-HA cultures showed
features of aggregates; moreover, markedly increased expres-
sion of Nestin, CD44, RHAMM, and CD133 in 3D-HA scaffolds
were found. Conclusions: the behavior of U87 in our 3D-HA
model is more similar to tumor growth in vivo and a stem-like
phenotype is promoted. Thus, the 3D-HA scaffold could pro-
vide a useful model for CSCs study and anti-cancer therapeu-
tics research in vitro and may have preclinical application for
the screening of drug candidates. VC 2014 Wiley Periodicals, Inc. J
Biomed Mater Res Part B: Appl Biomater 00B: 000–000, 2014.
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INTRODUCTION
Glioblastoma is one of the most lethal cancer types, and its
high malignancy leads to a median survival of only 12
months.1 Glioblastoma cells show resistance to radiotherapy
and chemotherapy, and this resistance is mainly thought to
be due to a subpopulation of highly resistant cancer stem
cells (CSCs).2,3 Such cells share many characteristics of stem
cells such as self-renewal capacity, undifferentiated state,
multipotential differentiation ability4; presence of cells with
increasingly undifferentiated state correlates with poor prog-
nosis of glioblastoma patients.5 In glioma, the presence of
neural progenitors expressing genes characteristic of neural
stem cells such as CD133, Sox2, musashi-1, bmi-1, able to
form neural spheres, has been described and is increasingly
studied due to its clinical relevance in glioma treatment.6–8
Thus, to develop successful strategies to treat gliomas, it
seems desirable to work with populations enriched in CSCs
as a worst-case scenario. Nevertheless, standard culture
conditions using two-dimensional (2D) substrates and
serum-containing medium do not favor the expression of a
CSC phenotype,9 and most works studying glioma CSCs use
serum-free media supplemented with costly growth factors
to induce CSC phenotype and obtain CSC-rich populations
from clinical specimens10 or standard cell lines.11
Generally, traditional 2D models are very limited and lead
to poor predictability of in vitro assays, which is no surprise,
as molecular targets are modulated by the microenvironment
including cell-cell, cell-stroma, and cell-matrix interaction, as
well as other mechanisms related to the tumor microarchi-
tecture (central hypoxia and lack of nutrients), all lacking in
a 2D petri dish. These differences in the microenvironment
cause changes in cytoskeletal organization, extracellular
matrix production, proliferation, or cell membrane receptor
expression to cite only a few.12,13 For that reason in the last
10 years three-dimensional (3D) models of growing using
scaffolds complexity have been developed in order to mimic
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more closely the tumor microenvironment,14–16 working with
multicellular aggregates or spheroids17 or with extracellular
matrix (ECM) based hydrogels Matrigel-like,18–20 which have
led to valuable forthcomings in the knowledge of pathological
mechanisms. Nevertheless those models present some prob-
lems due to the absence of cell-matrix interaction in the case
of spheroids such interaction is said to be determinant in the
cell response, especially to drugs13 and in the case of using
animal tissue derived matrix, there may be substantial varia-
tions of composition between batches which affect the repro-
ducibility of assays and comparative studies.21 For this
reason, recent work has been dedicated to engineer tumor-
ous constructs using synthetic porous materials such as poly
(L-lactic acid),22 poly(lactide-co-glycolide),23 or hydrogels
which production mode is more standardized and batch-to-
batch variability is more limited, as chitosan,24 collage-
n,25–27or hyaluronic acid (HA).28 This kind of model showed
to be more relevant physiologically29 reproducing tumor-like
characteristics as internal hypoxia,30 metabolic activity, or
paracrine secretion.24 Cells grown on 3D substrates have
shown high tumorigenicity when implanted in animals when
compared with 2D cultured cells.31 Most importantly, cell
survival upon treatment with standard antitumoral drugs
such as doxorubicin, paclitaxel or tamoxifen was significantly
higher in 3D constructs.22,24 Up to date, there is no signifi-
cant data studying the differentiation state of 3D cultured
tumoral cells or the influence of 3D culture on CSCs
subpopulations.
HA is present in high amounts in the tumor stroma, and
cancer is often accompanied by alterations of HA metabo-
lism.32 These alterations use to be related with a high grade
of malignancy and metastasis.32–34 HA interplays in several
tumorigenic mechanisms either directly (angiogenic effect of
oligomers of HA) or indirectly due to cancer cell interaction
mediated by membrane receptors CD44 and RHAMM. Can-
cer cell interaction with extracellular matrix polysaccharide
hyaluronan (HA), mostly mediated by membrane receptors
CD44 and RHAMM, induces a more aggressive and invasive
phenotype,35,36 but to date there have been no reports of
its influence on differentiation status of glioma cells. Here,
we wanted to investigate the hypothesis that 3D culture in
presence of hyaluronan induces a more undifferentiated
phenotype, which would prove useful for the study of gli-
oma CSCs and the development of therapies against glioma.
In this work, we use 3D materials consisting of a HA cell
carrier phase within synthetic polycaprolactone (PCL) scaf-
folds previously developed in our laboratory and study the
behavior of U87 glioma cells in presence of HA (3D-HA),
comparing their behavior with standard 3D culture in a PCL
scaffold (3D) or 2D culture on PCL plane samples (2D) to
assess their effect on differentiation state of U87 and their
suitability as 3D model cultures for drug discovery.
MATERIALS AND METHODS
Preparation of scaffolds and plane samples
Scaffolds were prepared by a mixed particle leaching/freeze
extraction process, as described previously.37 Acrylic micro-
spheres (Lucite International, mean diameter 200 m) were
used as a porogen. Polycaprolactone (PCL, Mn50 kDa, Pol-
ysciences) was dissolved at 20% (w/w) in dioxane and
mixed with the porogen in Teflon molds. Molds were
immersed in liquid nitrogen and frozen. Dioxane was
removed by freeze-extraction during 3 days at 220C in
ethanol. Then, porogen was leached in ethanol at 40C dur-
ing one week. Cylindrical samples of 5 mm diameter were
stamped out of the disks and height was homogenized to
3 mm.
For 2D controls, PCL was dissolved in chloroform (10%
w/v) and cast over Petri dishes. Solvent was allowed to
evaporate for 1 day and round disks of 8 mm diameter
were stamped out of the obtained films. All samples (plane
samples and scaffolds) were dried to constant weight and
irradiated with g-ray irradiation at 25 kGy before use for
cell culture.
Modification of hyaluronan
Hyaluronan (from Streptococcus Equi, Sigma-Aldrich,
Mn1.5 to 1.8 3 106 Da) was chemically modified in order
to allow for cell encapsulation following the protocol by
Darr and Calabro.38 Shortly, hyaluronan was dissolved in
MES buffer (250 mM) containing NaCl (150 mM) and NaOH
(75 mM) at pH 5.75. After complete dissolution, modifica-
tion of hydroxyl moieties with tyramine using carbodiimide
chemistry was carried out by mixing 2:1 molar ratio of tyra-
mine hydrochloride (Sigma-Aldrich, Spain) to hydroxyl moi-
eties of hyaluronan, 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDAC, 1:1 to tyramine; Sigma-Aldrich, Spain)
and N-hydroxysuccinimide (NHS, 1:10 to EDC; Sigma-
Aldrich, Spain). Reaction was carried out during 24h at
37C in water bath. Then obtained tyramine-substituted
hyaluronan (TS-HA) was dialyzed, first against 150 mM
NaCl, and then against ultrapure water. When used for cell
culture, TS-HA was first filtered at 0.2 um for sterilization
and lyophilized in a sterile vial. When used for material
characterization, TS-HA was directly lyophilized and was
stored in a dry vessel at 220C until experiments were per-
formed. Substitution grade reached evaluated through mea-
surement of spectrophotometric absorption at 470 nm38 in
NaCl 150 mM and comparison with a calibration curve of
free tyramine at the same wavelength.
Cell culture
U87 glioma cell line from ATCC was a generous gift of J.
Blanco, ICCC, Barcelona. Cells were cultured in standard
conditions using high glucose DMEM (Sigma-Aldrich, Spain)
supplemented with 1% glutamine, 1% P/S and 10% fetal
bovine serum (FBS, Gibco). All cultures were maintained in
a humidified incubator at 37C, 5% CO2, and 100% humid-
ity. After expansion, the cells were detached for the cell-
seeding experiments on scaffolds and plane samples.
Construct seeding and culture
PCL scaffolds were prehydrated overnight before seeding
either in DMEM with FBS (for PCL pure scaffolds, thereafter
described as 3D) or in phosphate buffer saline (PBS, for
the PCL samples containing TS-HA, thereafter described as
2
3D-HA). Two-dimensional plane samples were also incu-
bated with serum containing medium in order to favor pro-
tein adsorption on the surface and therefore cell adhesion
onto them.
Cells were trypsinized from the cell culture flasks using
trypsin-EDTA, and blocked using FBS. After centrifugation at
1000 rpm and counting, cells were resuspended in PBS
with 2 g/L glucose (PBS-G) at high density for seeding. Scaf-
folds were seeded at a density of 400,000 cells/scaffold,
whereas 2D was seeded at 50,000 cells/sample (this was
calculated to have an equivalent cell density per surface).
Three-dimensional was seeded using a volume of 30 lL/
scaffold using a micropipette. For 3D-HA samples, first the
concentrated (2x) cell suspension was mixed with an equal
concentration of TS-HA solution in PBS-G to which 1:100
horseradish peroxidase (HRP 100 units/mL, Sigma-Aldrich)
was added (TS-HA concentration had been previously calcu-
lated so as to have the nominal concentration after dilution
with HRP and cells). Three-dimensional HA was seeded
using a 250 lL syringe, injecting 30 lL of TS-HA/HRP/cells
mix in each scaffold. Each scaffold was deposited in a U-
bottom P96 well and 20 lL of hydrogen peroxide at 0.01%
(Sigma Aldrich) was added. Two-dimensional samples were
seeded at 0.5ml/well using a diluted cell suspension. Cells
were allowed to adhere and TS-HA was allowed to crosslink
for 1 hr, afterwards constructs were transferred on nonad-
herent 24-wells and covered with 750 lL DMEM supple-
mented with FBS. Half of the total volume of culture media
was exchanged by fresh every 2 days. Constructs were cul-
tured up to 7, 14, or 21 days and analyzed as described
subsequently.
Electron scanning microscopy
Cryo-SEM was used in order to observe the internal mor-
phology of TS-HA modified scaffolds (3D-HA, n52) in wet
state. For Cryo-SEM, wet samples were carefully wiped with
filter paper, mounted in a clamp, ultrafrozen, and then cryo-
fractured; the sublimation temperature used was 260C.
Finally, samples were gold sputtered in the same cold vac-
uum chamber of a JEOL JSM6300 electron microscope and
observed at an acceleration tension of 10 kV.
For observation of cell containing constructs, samples
were fixed at the end of culture time with 2.5% glutaralde-
hyde and dehydrated in a series of increasingly concentrated
ethanol. Samples were finally dried from hexamethyldisila-
zane, sputtered with gold and observed in a Hitachi S8400
electron microscope at an acceleration tension of 10 kV.
Hyaluronan content
The amount of crosslinked HA present in the scaffolds
was determined using a thermogravimetric analyzer (TGA)
from TA Instruments; samples were placed in a platinum
pan and subjected to a heating scan from 50 to 800C at
20C/min under nitrogen atmosphere. The mass was
monitored as a function of the temperature; results were
analyzed using the software TA Analyzer from the instru-
ment. Degradation peaks of HA and PCL were determined
using bare crosslinked HA and PCL samples: using
differential weight loss signal, onset and offset tempera-
tures of the first degradation peak associated to HA at
T5255C were determined. From the weight scan of pure
HA, it has been determined that the weight loss at this
temperature corresponds to 35% of the total mass of HA.
Weight loss percentage between these temperatures was
determined, and corresponding HA weight in the sample
was calculated.
Immunofluorescence imaging
At the end of culture time, three samples per group were
rinsed with 0.1M PBS, pH 7.4, and fixed for 15 min in 4%
paraformaldehyde (Panreac) at room temperature. There-
after they were cryoprotected by immersion in 0.1M PBS
containing 30% sucrose and included in OCT. Hundred
micrometer thick sections were obtained by using a cryo-
tome (Microm, HM 520) and washed with PBS. Samples
were washed with PBS and treated with 0.1M glycine for
autofluorescence quenching, and permeabilized using 0.5%
Triton X100 (Sigma) in HEPES buffer 20 mM (Sigma
Aldrich) supplemented with sucrose (Panreac, 10.3%),
sodium chloride (Sigma Aldrich, 0.292%), and magnesium
chloride (Scharlab, 0.06%). Blocking of unspecific sites was
realized with PBS supplemented with 1% bovine serum
albumin (BSA) for 1 h. Samples were then incubated with
primary antibodies overnight at room temperature. Anti-
bodies used were mouse anti Nestin (1:400, Abcam) with
rabbit anti-Glial fibrillary acidic protein (GFAP, 1:400,
DakoCytomation), or mouse anti-Vimentin (1:200, Sigma)
with rabbit anti-CD44 (1:100, Abcam). Samples were
washed with PBS containing 0.5% Tween 20 (Sigma-
Aldrich) twice and incubated for 1 h with secondary anti-
bodies (Alexa Goat anti Mouse 647 or Alexa Goat anti Rab-
bit 488, 1:400) at room temperature. Then, after washing
with PBS containing 0.5% Tween 20, samples were stained
with DAPI (1:5000, Sigma-Aldrich), washed with PBS and
mounted using home-made Mowiol (Calbiochem) based
mounting medium. Cells were observed in a Nikon Eclipse
80i fluorescence microscope or alternatively in an Olympus
FV1000 confocal microscope.
Cell viability assay
Cell viability was measured using a metabolic assay using
(3-(4,5-dimethylthiazol-2-yl)25-(3-carboxymethoxyphenyl)2
2-(4-sulfophenyl)22H-tetrazolium) (MTS, Promega) assay.
Samples at 1, 7, 14, and 21 days were washed using PBS,
and MTS reagent mixed with phenol red free medium (1:5
v/v) was added. Samples (n5 4 at each time point in cul-
ture) were incubated in the dark during 1h at 37C to allow
reduction of MTS to formazan due to metabolic activity.
Then aliquots were transferred to new wells and absorb-
ance at 490 nm was read using a Victor 3 multiplate reader.
Blank absorbances using unseeded materials were also read
and subtracted to obtained absorbances.
Cytometry analysis
Cytometric analysis of cell surface markers CD44, RHAMM
and CD133 was realized using a FC500 Cytomics cytometer
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from Beckman Coulter. Cells were detached from the materi-
als using mild enzymatic digestion with Accutase (Stempro),
and approximately 2 3 105 cells were incubated with anti-
bodies (CD44 (EPR1013Y epitope, Abcam, dilution 1:50)
and RHAMM (2D6 epitope, Abcam, dilution 1:50) in phos-
phate buffered saline with 1% BSA) for 30 min at 4C,
washed extensively with PBS, marked with secondary anti-
bodies (Alexa 647 and 488) for 30’ and washed with PBS.
For CD133, approximately 2 3 105 cells were incubated
with PE-CD133 antibody (Milteny Biotech, 1:30). Cells were
passed through the cytometer; secondary antibodies alone
or PE-IgG were used as epitope controls. Gating values were
determined using control cells grown on tissue grade TCPS
in the same conditions. At least 10,000 cells were counted
for each experiment (n5 6 samples), and experiments were
conducted in triplicate.
Statistical analysis
Homogeneity of the variances was tested using a Levene
Test in SPSS software. In case of homogeneity, analyses
were performed using an ANOVA test. In case of in homoge-
nous variances, a Kruskal Wallis test was used. For signifi-
cant tests, a post hoc Tuckey test was used. Significance
level was set at p< 0.05. The data collected are reported as
the mean6 standard deviation.
RESULTS
Material characterization
The PCL scaffolds present the typical structure obtained by
this technique, with a double porosity, macroporosity
related with the porogen leaching and microporosity due to
the phase separation and subsequent freeze extraction (Sup-
porting Information Figure S1). TS-Hyaluronan had a substi-
tution grade of 3% as determined using UV absorbance at
275 nm.38 When TS-hyaluronan was mixed with peroxidase
and injected inside of the pores in presence of hydroxide
peroxide, it was efficiently crosslinked and insolubilized
within the porous structure, as observed by Cryo-SEM (Fig-
ure 1). Using increasing concentrations of the TS-HA solu-
tion (2.5, 5, and 10 mg/mL), more space was occupied by
the hydrogel phase.
Correspondingly, when determined quantitatively by
TGA, the HA content showed to increase when using
increasingly concentrated solutions for crosslinking (Figure
2). Thus, content and consistency of the hydrogel phase in
the scaffolds can be easily tuned by varying the concentra-
tion of hyaluronan solution.
Cell culture
Cell seeding was optimized using different concentration of
hyaluronan, and efficiency was seen to be similar at all con-
centrations tested as shown by metabolic test at 2 h post-
seeding (Supporting Information Figure S2). MTS
absorbance on 3D-HA was slightly lower than in 3D con-
trols, but still good efficiency was obtained. Nevertheless, at
longer times there was a slight drop in absorbance values
that may be due to the leaching of cells at lower concentra-
tions, which we related with the low viscosity of the gel or
the possibility of some gel degradation during culture, and
FIGURE 1. Cryo-SEM micrographs of porous architecture of PCL scaffolds at different concentrations of the HA: 2.5 mg/mL (A, A0), 5 mg/mL (B,
B0) and 10 mg/mL (C, C0). Volume occupied by the hyaluronan gel increases at higher concentrations as observed on the micrographs. Scale
bars: 200 lm (A–C) and 40 lm (A0–C0).
FIGURE 2. Dry content of TS-HA in the 3D-HA constructs with differ-
ent concentrations of TS-HA (2.5, 5, and 10 mg/mL).
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so for further experiments, a concentration of 10 mg/mL
TS-HA was used in the 3D-HA samples.
Cells were cultivated up to 3 weeks showing sustained
metabolism during the culture time (Figure 3); nevertheless,
MTS results did not show an exponential increase in meta-
bolic rate as observed in other works.39 Rather the absorb-
ance remained stable over the weeks of culture, or
increased slightly. Possible reasons for this result will be
discussed later. We later checked viability using a live dead
staining kit, and observed that nearly all cells remained via-
ble after 14 days either in 2D [Supporting Information Fig-
ure S3(A)] or in the 3D construct [Supporting Information
Figure S3(B)].
The cell morphology was observed by scanning electron
microscopy (Figure 4): on 2D substrates [Figure 4(A)], cells
show a either spread or spindle-like shape and are ran-
domly distributed on the materials; when reaching conflu-
ence they tend to form aggregates. On 3D scaffolds [Figure
4(B)], cells spread also until covering the whole internal
surface of the pore and then also form locally aggregates. In
3D-HA samples [Figure 4(C)], cells show a round morphol-
ogy and are more prone to aggregate as clusters.
Cell phenotype in the different culture modes
On 3D culture, expression of cell-surface glycoprotein CD44
was slightly upregulated (Figure 5); this cell surface marker
was also upregulated when cultured in hyaluronan-modified
3D structures (3D-HA), although in none of the conditions
(3D or 3D-HA) differences were found to be statistically sig-
nificant. Expression of RHAMM was also upregulated when
cultivating in 3D, and further increased when cultivating in
hyaluronan hydrogels (significant difference with respect to
2D control). At least, expression of CD133 was increased
moderately on 3D culture (significant with respect to 2D)
and dramatically when cultivating in 3D in presence of hya-
luronan (3D-HA), showing statistically significant difference
(p<0.05) with respect to both 2D and 3D controls.
Cells were stained for Nestin, GFAP, Vimentin and
CD44, in order to observe possible modulation of the
expressed proteins due to culture mode and possible het-
erogeneities in the same sample. Results are shown in Fig-
ure 6: 2D samples showed staining for GFAP and CD44,
whereas poor staining for Vimentin or Nestin was
observed. In 3D, the staining for GFAP was more diffuse
and cells lacked the fibrillar protrusions seen in 2D; this
was more pronounced for 3D-HA samples; staining for
Nestin was nearly absent in 2D, but increased in 3D and in
3D-HA; interestingly, increasing intranuclear localization of
nestin staining was observed consistent with findings of
others.40,41 On the other hand, staining for Vimentin was
not observed for all cells in 3D and 3D-HA culture, consist-
ent with increasing phenotype heterogeneity in such cul-
tures. Staining for CD44 was seen sporadically in all
cultures and seemed to be more prominent in zones of
increased cell–cell contact.
FIGURE 3. MTS metabolic assay at different times of culture in vitro
(1, 7, 14, and 21 days) showing a slight increase in absorbance at
large culture times.
FIGURE 4. Cell morphology as observed by scanning electron microscopy after 21 days; for an easier observation of the adhesion and morphol-
ogy in each substrate, cells were colored blue using Adobe Photoshop: on 2D (A) cells were randomly distributed and exhibited a spindle-like
shape; on 3D (B) and 3D-HA (C) cells were formed aggregates and clusters. Scale bar: 50 lm. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
FIGURE 5. Evaluation of surface RHAMM, CD44 and CD133 expression
in U87 using flow cytometry after 21 days of culture in 2D, 3D, and
3D-HA. Significant increase (p< 0.05) with respect to 2D are shown




Numerous 3D cell culture models for cancer research are
currently under focus due to the limitations related with
traditional 2D cell culture models.15 Cell behavior is known
to be regulated by environmental factors, and 3D behavior
often varies when compared with 2D behavior in terms of
cytoskeletal development, cell marker expression, differen-
tiation, and so forth.12 Although various works have studied
the influence of 3D culture on glioma cells morphology, pro-
liferation, and response to cytostatic agents,25,42 little is
known about its influence on the differentiation state of gli-
oma cells, while high recurrence rate of glioblastoma has
been linked to the presence of subpopulations of CSCs.
Moreover, most works studying CSCs work use the spheroid
model6,10 that does not reproduce the cell-matrix interac-
tion component of cell response. In this work, we explore
the influence of 3D culture and presence of HA on the dif-
ferentiation state of U87 glioblastoma cell line.
PCL is widely used in bioengineering and tissue engi-
neering due to its biocompatibility and stability. PCL scaf-
folds (Supporting Information Figure S1) produced in our
lab show an interconnected pore structure and allow sus-
tained growth of different cell types.43,44 Besides, TS-
modified hyaluronan allows encapsulation of live cells in an
ECM-like microenvironment without significant loss of via-
bility, and also shows in vitro stability over several weeks,
being thus suitable for in vitro drug testing. Use of PCL
together with HA gel permits a better manipulation, as PCL
is much more rigid while HA is a very soft gel. U87 glioblas-
toma cells were found to proliferate and form neurosphere-
like structures in 2D and 3D when reaching locally conflu-
ency. Whereas such neurospheres were easily leached out of
2D cultures during medium changes, they could sustain a
consistent growth when sheltered by PCL 3D scaffold (3D)
and HA gel phase (3D-HA). Cell density in the 3D constructs
at large culture times were huge and similar to a tumor
microenvironment as observable from the confocal pictures.
Nevertheless, conversion of MTS into formazan was higher
in 2D control than in 3D samples in our study. Similar
results were obtained by Kievit et al.25 in vitro, which they
explained by a decreased mass transfer in 3D models as
well as central hypoxia in the constructs which leads to
decreased proliferation rates in absence of a vascular net-
work. In contrast to 2D cultures which have easy access to
nutrients and oxygen supplied by the culture medium, in
3D cultures, solutes must diffuse through the scaffold net-
work before becoming available to cells.
It is reported in literature that differences in basal
metabolism between 2D and 3D culture, as well as different
diffusion rate of MTS containing medium in dense 3D cul-
ture also represents a limiting factor when studying cell
proliferation in 3D.45 This can be seen in Figure 3 at first
day, where 2D and 3D samples show similar absorbances
values although 3D samples were seeded at much higher
density than 2D samples; absorbance in 3D-HA was still
lower, whereas the constructs were seeded at the same den-
sity as 3D constructs. We observed that there is a significant
adsorption of formazan compound onto the PCL scaffolds,
which cannot be accounted for using the blank value of the
curve (as in the blank value no transformation of MTS into
formazan occurs). We measured using control culture wells
and culture wells where a nonseeded PCL scaffold was
added, that absorbance of MTS at similar cell density was
decreased by 0.2 in the presence of a void scaffold due to
FIGURE 6. Double immunofluorescence staining showed expression of GFAP, Nestin (A–C) markers and CD44, Vimentin (D-F) in U87 cells. A, D:
U87 cells on 2D; B, E: U87 cells on 3D; C,F: U87 cells on 3D-HA (Scale bar: 20 mm). [Color figure can be viewed in the online issue, which is avail-
able at wileyonlinelibrary.com.]
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unspecific adsorption of formazan compound onto the scaf-
fold (unpublished data). Thus, values can only be compared
with respect to the same culture condition at different time
and cannot be directly related to the cell number. Some
studies suggest that other methods, such as XTT assay,
could be more convenient when studying the proliferation
of cells embedded in dense 3D matrices.46 Here, another
shortcoming is the leaching of cells during medium changes
(which was unavoidable although medium change was real-
ized changing 50% of medium each time), due to the tend-
ency of U87 to form spheroids and detach from the
materials, which can also explain that cell number does not
increase steadily at large culture times; as a matter of fact,
most articles using such models only study proliferation by
MTS at short times (<10 days).22,28,30 It is also known that
interaction of CD44 with high molecular weight HA leads to
a decreased proliferation, which is consistent with the lim-
ited increase in cell metabolism in 3D-HA constructs.
Cell morphology is dependent on culture substrate
micro and macrotopography, chemistry and mechanical
properties; it is well known that most cells show a fibro-
blastic morphology on hard and hydrophobic materials,
whereas they are usually more rounded on soft hydrogels
and hydrophilic materials.47 Such differences in cell shape
are not anecdotal as they influence further properties such
as nucleus shape,48 gene expression, proliferation,49 and dif-
ferentiation.50 In the case of tumor cells, invasiveness has
been shown to be related to cell morphology,51 and spindle
shape; fibroblast-like cells have been described as less
aggressive than rounded cells commonly found in spheroid
culture.25 Thus, HA influence in cell shape may reflect
deeper changes in the cell phenotype. To get further insights
into this, phenotypic profile of cells was studied both quali-
tatively using immunofluorescence and quantitatively using
flow cytometry. U87 is a cell line with high malignancy,
showing some dedifferentiation as shown by the expression
to several degrees in the different culture modes of mesen-
chymal marker vimentin, which in tumor cells is generally a
hallmark of increased dedifferentiation and thus virulence.
Nevertheless, some cells are also positive for GFAP, a marker
for differentiated astrocytes, showing that a subpopulation
of U87 maintains some features of differentiated cells. Gen-
erally, cells cultured in 3D culture and presence of HA tend
to show increased markers of dedifferentiation such as
Vimentin or Nestin. Nuclear localization of Nestin observed
in 3D and 3D-HA constructs has been observed in several
glioblastoma cell lines52 as well as in U87 xenograft in an
immunodeficient mouse model,40 and is thought to contrib-
ute to the regulation of gene expression.41 In order to inves-
tigate more quantitatively the stemness of 3D cultured U87
and the influence of HA in 3D culture, both CD133
(stemness marker) and CD44/RHAMM (HA main receptors)
were studied by flow cytometry. Cytometry is currently
gaining increasing acceptance for the analysis of tissue engi-
neered constructs, as it permits a quantitative analysis of
cell marker expression and study of population heterogene-
ity within such constructs.27,53 CD133, or prominin, is
generally described as the main CSC marker for glioma,
while interaction of cells with HA through CD44 and
RHAMM recruitment is known to increase malignancy.35,36
We observed that CD44 expression was not significantly dif-
ferent between 2D, 3D, and 3D-HA, whereas RHAMM was
upregulated in presence of HA and CD133 was upregulated
in 3D and most in 3D-HA. CD44, is the main receptor of
hyaluronan, and is expressed in many cancer cell types. In
some cancer types, overexpression of CD44 is linked to
increased malignancy of cancer cells.54,55 Most studied is
the interaction between CD44 and HA; the binding of CD44
isoforms to hyaluronan affects cell adhesion to extracellular
matrix components and is implicated in the stimulation of
aggregation, proliferation and migration of cancer cells.
RHAMM was specifically sensible to the presence of HA in
3D culture; in glioma, RHAMM has been related to increased
proliferation and migration potential, and soluble RHAMM
competing with endogenous RHAMM was shown to inhibit
both proliferation and migration of cells. In various cancer
types, CD1331 cells have been proposed as containing a
subpopulation of cancer cells with stem-like properties.
CD133 positive cells have been shown to have some drug
effluxing mechanisms normally found in stem cells,56–59
which could explain their increased resistance to chemo-
therapy; moreover, they have DNA repair mechanisms that
confer them radioresistance. Our in vitro experiments show
that CD133 marker cell have more expression on 3D than in
2D and that presence of HA in the constructs further pro-
motes a stem-like phenotype. The more undifferentiated
phenotype observed in 3D cultures may be related with sev-
eral factors, among them increased cell–cell contact in the
3D model, spatial heterogeneity, restriction in diffusion lead-
ing to central hypoxia and eventually local accumulation of
acidic residues.60 As a matter of fact, hypoxia has been
described as a key factor inducing the dedifferentiation of
glioma cells.2,61 Several studies reported that porous 3D
structures can significantly improve the communications of
cell–ECM and provide a hypoxic microenvironment.62,63
These intimate interactions (cell–cell and cell–substrate)
provoke modifications of cell activities such as proliferation,
differentiation, apoptosis, and secretion of soluble factors
and deposition of ECM components, and have been shown
to enhance malignant phenotypes in 3D structures; now
these results tend to prove that they also increase the dedif-
ferentiation of glioma cells and promote a CSC phenotype.
RHAMM, that was significantly upregulated in presence of
HA, may be implied in the crosstalk between HA microen-
vironment, hypoxia, and CD133 expression. Further studies
with this new 3D-HA system shall shed light on the mecha-
nisms implied.
CONCLUSIONS
In this study, we developed innovative 3D scaffolds (3D and
3D-HA) to mimic in vitro the structure of the tumor with
controlled and tunable architectural features. Both scaffolds
support cell proliferation, migration, increase of cell cluster-
ing and changes in phenotypic expression; besides, 3D-HA
construct promotes overexpression of specific stem cell
ORIGINAL RESEARCH REPORT
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surface marker CD133. This 3D-HA system leads to a natural
enrichment in CSCs in standard culture conditions and may
prove useful as in vitro model for drug development studies.
Moreover, as it provides realistic cell-matrix interactions, it
should permit to study the influence of microenvironment on
drug and radiation resistance mechanisms by CSCs.
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